Articles > Medpace Holdings, Inc. Facing Securities Class Action Lawsuits
- Rosen Law Firm reminds Medpace Holdings, Inc. investors of June 8, 2026 deadline to seek lead plaintiff role in securities class action
- Faruqi & Faruqi, LLP is investigating potential claims against Medpace Holdings, Inc.
- Levi & Korsinsky alerts investors of pending securities class action against Medpace Holdings, Inc.
- Schall Law Firm reminds investors of class action lawsuit against Medpace Holdings, Inc.
- DJS Law Group files class action lawsuit against Medpace Holdings, Inc. for securities law violations
New York, New York--(Newsfile Corp. - June 3, 2026) - Rosen Law Firm, a global investor rights law firm, is urging investors who purchased common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025, and February 9, 2026, to take action before the important June 8, 2026, lead plaintiff deadline. The firm is offering assistance to investors with losses exceeding $100,000 to secure counsel and potentially seek compensation through a contingency fee arrangement.
Furthermore, Faruqi & Faruqi, LLP, a national securities law firm, is conducting an investigation into potential claims against Medpace Holdings, Inc. The firm reiterates the June 8, 2026 deadline for investors to seek the role of lead plaintiff in a federal securities class action filed against the company.
Levi & Korsinsky, LLP, a prominent law firm, is alerting investors in Medpace Holdings Inc., of a pending securities class action lawsuit that names senior executives as individual defendants. Allegations involve misleading statements made by the CEO during the Class Period from April 22, 2025, through February 9, 2026.
Similarly, the Schall Law Firm is reminding investors of a class action lawsuit against Medpace Holdings, Inc. The lawsuit alleges violations of securities laws and encourages investors who purchased the company's securities during the Class Period to contact the firm before June 5, 2026, to discuss their legal options.
Lastly, the DJS Law Group has filed a class action lawsuit against Medpace Holdings, Inc. for violations of securities laws. The firm advises shareholders who acquired shares of MEDP during the specified Class Period to reach out regarding possible lead plaintiff appointments. Investors are encouraged to seek legal counsel to explore potential remedies available.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Medpace Holdings, Inc. Facing Securities Class Action Lawsuits
By KlickAnalytics Data Insights | June 3, 2026 08:03PM ET
Key Points
- Rosen Law Firm reminds Medpace Holdings, Inc. investors of June 8, 2026 deadline to seek lead plaintiff role in securities class action
- Faruqi & Faruqi, LLP is investigating potential claims against Medpace Holdings, Inc.
- Levi & Korsinsky alerts investors of pending securities class action against Medpace Holdings, Inc.
- Schall Law Firm reminds investors of class action lawsuit against Medpace Holdings, Inc.
- DJS Law Group files class action lawsuit against Medpace Holdings, Inc. for securities law violations
New York, New York--(Newsfile Corp. - June 3, 2026) - Rosen Law Firm, a global investor rights law firm, is urging investors who purchased common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025, and February 9, 2026, to take action before the important June 8, 2026, lead plaintiff deadline. The firm is offering assistance to investors with losses exceeding $100,000 to secure counsel and potentially seek compensation through a contingency fee arrangement.
Furthermore, Faruqi & Faruqi, LLP, a national securities law firm, is conducting an investigation into potential claims against Medpace Holdings, Inc. The firm reiterates the June 8, 2026 deadline for investors to seek the role of lead plaintiff in a federal securities class action filed against the company.
Levi & Korsinsky, LLP, a prominent law firm, is alerting investors in Medpace Holdings Inc., of a pending securities class action lawsuit that names senior executives as individual defendants. Allegations involve misleading statements made by the CEO during the Class Period from April 22, 2025, through February 9, 2026.
Similarly, the Schall Law Firm is reminding investors of a class action lawsuit against Medpace Holdings, Inc. The lawsuit alleges violations of securities laws and encourages investors who purchased the company's securities during the Class Period to contact the firm before June 5, 2026, to discuss their legal options.
Lastly, the DJS Law Group has filed a class action lawsuit against Medpace Holdings, Inc. for violations of securities laws. The firm advises shareholders who acquired shares of MEDP during the specified Class Period to reach out regarding possible lead plaintiff appointments. Investors are encouraged to seek legal counsel to explore potential remedies available.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.